Table 3.
Assay | Unit(s) | Value for: |
|
---|---|---|---|
MP-IV-1 | QQ-437 | ||
Aqueous solubility (pH 7.4) | μM | 50.82 | NDa |
Plasma protein binding by ultrafiltration | Mean % bound measured | 99.86 | ND |
Lipid-PAMPA | −Log P appb | 4.64 ± 0.06c | ND |
% recovery | 103.77 ± 1.78c | ND | |
CYP2C9 inhibition | % inhibition at 10 μM | 71.32 | 22 |
CYP2D6 inhibition | % inhibition at 10 μM | 15.50 | −3 |
CYP3A4 inhibition | % inhibition at 10 μM | −7.69 | −1 |
Cell-based hERG screening | IC50 (μM) | >300 | ND |
Chemical stability | % remaining after 60 min | 100 | ND |
Human liver microsome stability | % remaining after 30 min | 1.58 | 53.6 |
Half-life (min) | <10 | 33 | |
Human liver microsome stability (without NADPH) | % remaining after 30 min | 88.2 | ND |
Human hepatocyte stability | % remaining after 60 min | ND | 23 |
Mouse intravenous plasma concn (at 5 mg/kg) | ng/ml after 0.083 h | 2,343 | ND |
ng/ml after 0.25 h | 335 | ND | |
ng/ml after 0.5 | 108 | ND | |
ng/ml after 1 h | 28.4 | ND |
ND, not done.
−Log P app, where P app is the apparent permeability, in cm/s.
Values are means ± standard deviations.